Christopher M. Lindblom
No más puestos en curso
Perfil
Christopher M.
Lindblom worked as Secretary, Treasurer, SVP-Finance & Administration at DNIB Unwind, Inc. from 2014 to 2016.
Prior to that, he was Chief Accounting Officer & Vice President-Finance at Infinity Pharmaceuticals, Inc. from 2006 to 2013.
He also worked as Treasurer & Vice President-Finance at Infinity Pharmaceuticals, Inc. in 2016 and at OvaScience, Inc. in 2014.
Lindblom holds an MBA from Boston College and an undergraduate degree from Syracuse University.
Antiguos cargos conocidos de Christopher M. Lindblom.
Empresas | Cargo | Fin |
---|---|---|
INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 25/07/2016 |
DNIB UNWIND INC | Director of Finance/CFO | 21/03/2016 |
INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 12/04/2013 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Director of Finance/CFO | 07/06/2013 |
Formación de Christopher M. Lindblom.
Boston College | Masters Business Admin |
Syracuse University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
DNIB Unwind, Inc.
DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher M. Lindblom